Physician profile
Lisa C Walker
NPI 1578571816
$25,838.29
in general payments reported to CMS, 2019-2025
44 companies · $4,635 in 2025
The $4,635 reported for 2025 was more than what 89% of Dermatology providers received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,464 · 2020: $962 · 2021: $1,718 · 2022: $2,996 · 2023: $4,453 · 2024: $8,610 · 2025: $4,635.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $14K · Consulting Fee: $3,250 · Education: $99.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $14,347.86 |
| Consulting Fee | $3,250.00 |
| Education | $99.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $4,320.90 | 2019-2025 | Bimzelx |
| Abbvie INC. | $4,278.04 | 2019-2025 | Skyrizi, Rinvoq |
| Genzyme Corporation | $1,760.98 | 2019-2025 | |
| Lilly USA, LLC | $1,609.44 | 2019-2025 | Taltz, Olumiant, Ebglyss |
| E.R. Squibb & Sons, L.L.C. | $1,311.43 | 2022-2025 | Sotyktu |
| Janssen Biotech, INC. | $1,254.23 | 2019-2025 | Tremfya |
| Galderma Laboratories, L.P. | $1,223.29 | 2019-2025 | Nemluvio, Aklief, Twyneo |
| Regeneron Healthcare Solutions, INC. | $1,116.61 | 2019-2025 | Dupixent, Libtayo |
| Janssen Scientific Affairs, LLC | $1,089.65 | 2019-2025 | Tremfya |
| Arcutis Biotherapeutics, INC. | $872.51 | 2023-2025 | Zoryve |
| Amgen INC. | $721.85 | 2022-2025 | Otezla, Otezla |
| Pfizer INC. | $694.09 | 2022-2025 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $693.62 | 2019-2025 | Siliq, Cabtreo, Arazlo |
| Incyte Corporation | $681.99 | 2022-2025 | Opzelura |
| Sun Pharmaceutical Industries INC. | $605.66 | 2019-2025 | Absorica Ld, Winlevi, Ilumya |
Show all 44 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vyne Pharmaceuticals INC. | $430.92 | 2020-2021 | |
| Dermavant Sciences, INC. | $423.48 | 2023-2024 | Vtama |
| Novartis Pharmaceuticals Corporation | $420.43 | 2019-2025 | |
| Almirall LLC | $321.47 | 2019-2023 | Klisyri |
| Leo Pharma INC. | $318.13 | 2019-2025 | Adbry, Spevigo |
| Biofrontera INC. | $196.87 | 2019-2025 | Ameluz, Xepi, Bf-Rhodoled |
| Helsinn Therapeutics (U.S.), INC. | $188.50 | 2019-2023 | Valchlor |
| Boehringer Ingelheim Pharmaceuticals, INC. | $175.60 | 2023-2025 | Spevigo |
| Journey Medical Corporation | $149.67 | 2022 | |
| Revance Therapeutics, INC. | $147.96 | 2024 | Daxi |
| Allergan, INC. | $137.41 | 2020 | |
| Aclaris Therapeutics, INC. | $124.98 | 2019 | |
| Glaxosmithkline, LLC. | $107.96 | 2021 | |
| Paratek Pharmaceuticals, INC. | $96.12 | 2022 | |
| Kci USA, INC. | $62.50 | 2019 | |
| Tactile Systems Technology INC | $42.55 | 2021-2025 | Flexitouch Plus, Nimbl |
| Nabriva Therapeutics, Plc | $37.42 | 2022 | |
| Mayne Pharma Commercial LLC | $33.31 | 2019-2022 | |
| Krystal Biotech INC | $27.20 | 2024 | Vyjuvek |
| Integra Lifesciences Corporation | $21.77 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Cipher Pharmaceuticals US LLC | $20.46 | 2025 | Spinosad, Natroba |
| Sientra, INC. | $19.71 | 2020 | |
| Kyowa Kirin, INC. | $18.64 | 2022 | |
| Acera Surgical, INC. | $18.38 | 2022 | |
| Kerecis Limited | $15.82 | 2021 | |
| Celgene Corporation | $13.46 | 2019 | |
| Mylan Pharmaceuticals INC. | $11.95 | 2019 | |
| Genentech USA, INC. | $11.09 | 2019 | |
| Organon LLC | $10.24 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Walker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.